Anoro Ellipta

Anoro Ellipta should not be used in individuals with a known hypersensitivity to umeclidinium, vilanterol, or any other components of the inhaler. It is also contraindicated in patients with severe hypersensitivity to milk proteins, as the inhaler contains lactose. Patients with acutely deteriorating COPD or those who require emergency intervention should not use Anoro Ellipta.

When using Anoro Ellipta, it’s important to follow the instructions provided by your healthcare provider for proper inhalation technique. Always inhale the medication deeply to ensure it reaches the lungs. After using the inhaler, rinse your mouth with water and spit it out to reduce the risk of oral infections, such as thrush. Do not use this medication to treat sudden breathing problems—use a rescue inhaler for acute symptoms. Store the inhaler at room temperature, away from moisture and heat, and keep it out of reach of children.

Common side effects of Anoro Ellipta include sore throat, sinusitis, cough, headache, and dizziness. Serious side effects may include paradoxical bronchospasm (worsening breathing problems), irregular heartbeats, high blood pressure, and allergic reactions. If you experience any severe reactions, such as difficulty breathing, chest pain, or signs of an allergic reaction (e.g., rash, swelling, difficulty breathing), seek medical attention immediately.

The major risks associated with Anoro Ellipta include the potential for paradoxical bronchospasm, which can be life-threatening, and an increased risk of cardiovascular events, particularly in patients with pre-existing cardiovascular conditions. This medication may also cause worsening of narrow-angle glaucoma and urinary retention in patients with benign prostatic hyperplasia (BPH). It is important to discuss these risks with your healthcare provider and report any concerning symptoms promptly.

Anoro Ellipta may interact with other medications, including beta-blockers, diuretics, and certain antidepressants (e.g., MAO inhibitors, tricyclic antidepressants). These interactions can increase the risk of cardiovascular side effects, such as irregular heartbeats or high blood pressure. Avoid using other long-acting beta-agonists or anticholinergic medications while on Anoro Ellipta. Always inform your healthcare provider of all medications and supplements you are taking before starting Anoro Ellipta.

Alternative treatments to Anoro Ellipta for COPD may include other combination inhalers, such as Advair (fluticasone/salmeterol), Symbicort (budesonide/formoterol), or Stiolto Respimat (tiotropium/olodaterol). Depending on the severity of the condition, long-acting muscarinic antagonists (LAMAs) or short-acting bronchodilators may also be considered as alternatives.